Genective
Updated: 7 hours ago
Project Type: Sell-Side Representation
Clients: Vilmorin & Cie & Genective
Regions: United States / France
Description: Vilmorin & Cie divests its trait development platform, Genective, to The Traits Company, a subsidiary of GDM
Investment Highlights:
Genective's teams have developed valuable scientific expertise and a portfolio of innovative traits addressing important insect-resistance challenges in corn and soybean production
Created in 2013, Genective has been dedicated to the development of genetically modified traits. Since January 2025, Genective has been wholly owned by Vilmorin & Cie
The sale of Genective’s intellectual property to The Traits Company, GDM’s technology partner, reflects Vilmorin's shift towards emerging technologies and new innovations in genome editing and AI-enabled breeding, while preserving the value generated by Genective’s scientific achievements over the past several years.
Comments